AlphaOS

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

BCLI

BRAINSTORM CELL THERAPEUTICS INC.

Healthcare · Biological Products, (No Diagnostic Substances)

$1.17Jul 16, 2026

AI confidence 50% · prior close shown (market closed)

Investment Snapshot

Limited proprietary earnings coverage for BCLI yet — signals will sharpen as filings and earnings are ingested.

Pipeline evidence · 17d ago

BCLI's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on BCLI.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for BRAINSTORM CELL THERAPEUTICS INC. (BCLI) — events, not interpretation.

Event
Last session July 16, 2026 at $1.17.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Healthcare · Biological Products, (No Diagnostic Substances)

Investment Snapshot above is the primary AlphaOS analysis for BRAINSTORM CELL THERAPEUTICS INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Biological Products, (No Diagnostic Substances)
Market cap:
$12.91M

BCLI earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow BRAINSTORM CELL THERAPEUTICS INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related stock research

Connected companies and research pages from the AlphaOS knowledge graph.